More jobs go: Lonza cuts 500


Swiss speciality chemical company Lonza is to cut 500 jobs over the next two years to save costs, including 400 cut in a bid to ‘secure the future’ of the site at Visp in Switzerland.

The company says that the site has been insufficiently profitable in recent years because of competition from ‘low-cost manufacturers’, a strong Swiss franc and high prices for oil and energy. It would realise ‘the majority’ of cuts through internal transfers, natural attrition, early retirement and discontinuation of temporary contracts.

The Visp site is the largest, employing 2890 people, and one of the most significant for both production and R&D.

The company announced the cuts alongside financial results for the third quarter (Q3) of 2012. It described overall business performance as ‘on a satisfactory level despite difficult macroeconomic challenges’.


Related Content

Huntsman looks to cut jobs and titania capacity

8 December 2014 Business

news image

900 employees face axe as firm evaluates titanium dioxide options

Ashland cuts jobs in global reshuffle

28 January 2014 Business

news image

Speciality chemicals maker will axe 800-1000 positions and relocate 800-1000 more during 2014

Most Read

US government science institute's one time police chief linked to campus meth lab

31 July 2015 News and Analysis

news image

Explosion injuring a member of the National Institute of Standards and Technology's security force uncovered methamphetamine ...

(–)-Jiadifenolide

27 July 2015 Organic Matter

news image

BRSM wonders what makes a route so good it becomes the last total synthesis of a complex target

Most Commented

Scientist imprisoned over fraudulent HIV vaccine research

6 July 2015 News and Analysis

news image

Former Iowa State University researcher gets four-and-a-half years in prison for faking vaccine research funded by the NIH

Single polymer pill could deliver entire drug course in one go

27 July 2015 Research

news image

Flexible elastomer ring springs open to stay in stomach and could slowly release drugs over days